Cargando…

Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria

INTRODUCTION: In September 2015, Nigeria was removed from the list of polio-endemic countries after more than 12 months had passed since the detection of last wild poliovirus case in the country on 24 July 2014. We are presenting here a report of two polio seroprevalence surveys conducted in Septemb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iliyasu, Zubairu, Verma, Harish, Craig, Kehinde T., Nwaze, Eric, Ahmad-Shehu, Amina, Jibir, Binta Wudil, Gwarzo, Garba Dayyabu, Gajida, Auwalu U., Weldon, William C., Steven Oberste, M., Takane, Marina, Mkanda, Pascal, Muhammad, Ado J.G., Sutter, Roland W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036508/ https://www.ncbi.nlm.nih.gov/pubmed/27591950 http://dx.doi.org/10.1016/j.vaccine.2016.08.058

Ejemplares similares

Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria
por: Verma, Harish, et al.
Publicado: (2018)

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children
por: Tagbo, Beckie N, et al.
Publicado: (2020)

Survey of poliovirus antibodies in Borno and Yobe States, North-Eastern Nigeria
por: Gofama, Mustapha Modu, et al.
Publicado: (2017)

Public Health Innovations on the Way to Interruption of Poliovirus Transmission in Nigeria
por: Vaz, Rui G., et al.
Publicado: (2016)

Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar
por: Razafindratsimandresy, Richter, et al.
Publicado: (2018)

Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011–2014
por: Craig, Kehinde TemilolaOluwa, et al.
Publicado: (2016)

Seroprevalence of Poliovirus Antibodies in the United States Population, 2009–2010
por: Wallace, Gregory S., et al.
Publicado: (2016)

Contribution of Environmental Surveillance Toward Interruption of Poliovirus Transmission in Nigeria, 2012–2015
por: Johnson Muluh, Ticha, et al.
Publicado: (2016)

Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014
por: Gamage, Deepa, et al.
Publicado: (2015)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015)

Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States
por: Marin, Mona, et al.
Publicado: (2017)

Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan
por: Saleem, Ali Faisal, et al.
Publicado: (2017)

Immunogenicity of poliovirus vaccines in chronically malnourished infants: A randomized controlled trial in Pakistan
por: Saleem, Ali Faisal, et al.
Publicado: (2015)

Predictors of Safer Conception Practices Among HIV-Infected Women in Northern Nigeria
por: Iliyasu, Zubairu, et al.
Publicado: (2019)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials( )
por: Gast, Christopher, et al.
Publicado: (2021)

Direct detection of polioviruses using a recombinant poliovirus receptor
por: Gerloff, Nancy, et al.
Publicado: (2021)

“A child with sickle cell disease can't live with just anyone.” A mixed methods study of socio‐behavioral influences and severity of sickle cell disease in northern Nigeria
por: Iliyasu, Zubairu, et al.
Publicado: (2020)

Prevalence and Predictors of Tuberculosis Coinfection among HIV-Seropositive Patients Attending the Aminu Kano Teaching Hospital, Northern Nigeria
por: Iliyasu, Zubairu, et al.
Publicado: (2009)

A spatial model of Wild Poliovirus Type 1 in Kano State, Nigeria: calibration and assessment of elimination probability
por: McCarthy, Kevin A., et al.
Publicado: (2016)

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2020)

The re-emergence of wild poliovirus type 1 in Africa and the role of environmental surveillance in interrupting poliovirus transmission
por: Gwinji, Phanuel Tawanda, et al.
Publicado: (2022)

Estimating the Extent of Vaccine-Derived Poliovirus Infection
por: Wringe, Alison, et al.
Publicado: (2008)

The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines
por: Jia, Siyue, et al.
Publicado: (2020)

Cold chain and virus‐free chloroplast‐made booster vaccine to confer immunity against different poliovirus serotypes
por: Chan, Hui‐Ting, et al.
Publicado: (2016)

Mucosal immunity to poliovirus
por: Connor, Ruth I., et al.
Publicado: (2021)

Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan
por: Saleem, Ali Faisal, et al.
Publicado: (2018)

Towards an effective poliovirus laboratory containment strategy in Nigeria
por: Ticha, Johnson Muluh, et al.
Publicado: (2018)

Regulatory Aspects of Sabin Type 2 Withdrawal From Trivalent Oral Poliovirus Vaccine: Process and Lessons Learned
por: Decina, Daniela, et al.
Publicado: (2017)

Progress Toward Poliovirus Containment Implementation — Worldwide, 2018–2019
por: Moffett, Daphne B., et al.
Publicado: (2019)

Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame
por: Pons-Salort, Margarita, et al.
Publicado: (2016)

Facility and care provider emergency preparedness for neonatal resuscitation in Kano, Nigeria
por: Usman, Fatima, et al.
Publicado: (2022)

Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry
por: Macklin, Grace, et al.
Publicado: (2017)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials
por: Sáez-Llorens, Xavier, et al.
Publicado: (2021)

Group effort from poliovirus
por: Wells, William A.
Publicado: (2006)

Revealing the Poliovirus’s Path to Infection
por: Gross, Liza
Publicado: (2007)

The Case for Live Poliovirus Vaccination
por: Paul, John R.
Publicado: (1960)

Molecular aspects of poliovirus pathogenesis
por: Nomoto, Akio
Publicado: (2007)

Comparative epidemiology of poliovirus transmission
por: Noori, Navideh, et al.
Publicado: (2017)

The mechanism of RNA recombination in poliovirus
por: Kirkegaard, Karla, et al.
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_t84m6f8crl7c0a6a9hr5cn6eu5